AngioWaveNet vs Bunkerhill ECG-EF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AngioWaveNet

by AngioWave

Bunkerhill ECG-EF

by Bunkerhill Health

AI Verdict

AngioWaveNet is an AI tool designed to enhance fluoroscopic angiograms for improved vessel visualization during cardiac catheterization procedures. In contrast, Bunkerhill ECG-EF is an AI algorithm that analyzes 12-lead ECGs to detect reduced left ventricular ejection fraction, aiding in the early identification of patients at risk for heart failure. While both operate within cardiology, they address different clinical needs using distinct data types and applications, making them adjacent rather than direct competitors.

Choose AngioWaveNet if…

Choose AngioWaveNet if your cardiac catheterization lab requires enhanced, real-time visualization of blood vessels and anatomical structures during fluoroscopic angiograms. This tool is ideal for interventional cardiologists and vascular surgeons who need clearer imaging to guide complex procedures and improve diagnostic accuracy within existing Cath lab workflows.

View AngioWaveNet →

Choose Bunkerhill ECG-EF if…

Choose Bunkerhill ECG-EF if your practice or hospital needs a rapid, non-invasive screening tool to identify patients at risk for reduced left ventricular ejection fraction (LVEF ≤ 40%) using routine 12-lead ECGs. This AI algorithm is best suited for early identification of potential heart failure patients in settings like emergency medicine, internal medicine, or general cardiology, facilitating timely follow-up and intervention.

View Bunkerhill ECG-EF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AngioWaveNet	Bunkerhill ECG-EF
Pricing	Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available.	Contact sales for pricing details.
Deployment	Cloud-based or on-premise/servers	Cloud-native platform (Carebricks) that integrates with existing health system infrastructure like EHRs.
FDA Status	Cleared AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools emphasize seamless integration into existing clinical workflows. AngioWaveNet highlights vendor-agnostic compatibility and DICOM endpoint functionality for Cath labs, while Bunkerhill ECG-EF focuses on integration with EHRs and ECG Management Systems. Without specific UI/UX details, both appear designed for high usability within their respective clinical contexts.

Clinical Value

Bunkerhill ECG-EF

While both are FDA-cleared and offer significant clinical benefits, Bunkerhill ECG-EF provides early identification of reduced Left Ventricular Ejection Fraction (LVEF) from routine ECGs, a non-invasive and widely accessible test. This early detection of a critical heart failure risk factor from existing data offers a potentially broader and more impactful clinical value for population health and preventative care compared to AngioWaveNet's enhancement of angiogram visualization during a procedure.

Pricing & Value

AngioWaveNet

AngioWaveNet offers more transparent pricing options, including annual software licensing or subscription-based access tailored to cath lab volume and hospital needs, with custom packages available. Bunkerhill ECG-EF's pricing is listed as 'contact for pricing,' which provides less upfront information for potential buyers.

Enterprise Readiness

AngioWaveNet

Both tools are FDA-cleared and HIPAA compliant, indicating a strong foundation for enterprise use. However, AngioWaveNet offers flexible deployment options (cloud-based or on-premise/servers), which caters to a wider range of enterprise IT infrastructure preferences and security policies. While Bunkerhill ECG-EF mentions a BAA, AngioWaveNet's deployment flexibility provides a slight edge in enterprise adaptability.

Innovation

Bunkerhill ECG-EF

Bunkerhill ECG-EF demonstrates a higher degree of innovation by extracting a new, critical diagnostic insight (reduced LVEF) from widely available and inexpensive routine ECG data. This transforms an existing data source into a powerful screening tool for heart failure risk. AngioWaveNet, while valuable, focuses on enhancing existing angiographic images, which is an improvement on an established process rather than unlocking entirely new diagnostic capabilities from existing data.

Support & Docs

Tie

Neither the provided structured facts nor general web searches yield specific details regarding the level of support, documentation, training, or service level agreements (SLAs) offered by either AngioWaveNet or Bunkerhill ECG-EF. Without this information, it is not possible to differentiate between the two on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AngioWaveNet	Bunkerhill ECG-EF
Name	AngioWaveNet	Bunkerhill ECG-EF
Company	Angiowave Imaging	BunkerHill Health
Description	FDA-cleared AI software that enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories, integrating with existing Cath lab workflows.	FDA-cleared artificial intelligence algorithm by BunkerHill Health that detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead electrocardiograms (ECGs), aiding in the early identification of patients at risk for heart failure.
Primary Function	Enhances fluoroscopic angiograms for improved vessel visualization.	Detects reduced Left Ventricular Ejection Fraction (LVEF u2264 40%) from routine 12-lead ECGs.
Specialties	Cardiology, Interventional Radiology, Vascular Surgery	Cardiology, Emergency Medicine, Internal Medicine
Vendor Agnostic	Compatible with any fluoroscopic angiography system (vendor-agnostic)	Not specified

Videos

Demos, reviews, and walkthroughs featuring AngioWaveNet and Bunkerhill ECG-EF.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical problem each AI tool addresses?

AngioWaveNet is FDA-cleared AI software that enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories. Bunkerhill ECG-EF is an FDA-cleared AI algorithm that detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead electrocardiograms (ECGs), aiding in the early identification of patients at risk for heart failure.

What type of patient data does each tool utilize and how does it integrate into existing clinical systems?

AngioWaveNet processes fluoroscopic angiograms and integrates with existing Cath lab workflows, functioning as a DICOM endpoint for imaging systems. Bunkerhill ECG-EF analyzes routine 12-lead ECG data and integrates seamlessly with Electronic Medical Records (EMR) or ECG Management Systems.

Which medical specialties are the primary users for each AI solution?

AngioWaveNet is designed for Cardiology, Interventional Radiology, and Vascular Surgery. Bunkerhill ECG-EF is intended for Cardiology, Emergency Medicine, and Internal Medicine.

What are the key unique features of each tool?

AngioWaveNet features AI-powered Spatiotemporal Enhancement Processing (STEPu2122) and is compatible with any fluoroscopic angiography system (vendor-agnostic). Bunkerhill ECG-EF is a software-only medical device that provides a non-invasive, rapid, and accessible cardiac diagnostic tool to aid in early identification of patients at risk for heart failure.